HONGHUI(002802)2023-04-28 16:00Financial Performance - The company's revenue for Q1 2023 was ¥82,377,878.27, a decrease of 42.96% compared to ¥144,426,730.86 in the same period last year[4] - Net profit attributable to shareholders was ¥10,477,935.23, down 34.22% from ¥15,928,776.44 year-on-year[4] - The net profit after deducting non-recurring gains and losses was ¥7,061,235.32, reflecting a decline of 52.16% compared to ¥14,759,655.87 in the previous year[4] - Basic and diluted earnings per share were both ¥0.07, down 41.67% from ¥0.12 in the previous year[4] - Total operating revenue for Q1 2023 was ¥82,377,878.27, a decrease of 42.9% compared to ¥144,426,730.86 in the same period last year[19] - Total operating costs for Q1 2023 were ¥73,916,695.73, down 41.8% from ¥127,164,254.31 year-over-year[19] - Net profit for Q1 2023 was ¥10,477,935.23, a decline of 34.3% from ¥15,928,776.44 in Q1 2022[21] - The total comprehensive income attributable to the parent company was CNY 10,477,935.23, a decrease of 34.5% compared to CNY 15,928,776.44 in the previous period[22] - Basic and diluted earnings per share were both CNY 0.07, down from CNY 0.12 in the previous period, reflecting a decline of 41.7%[22] Cash Flow and Assets - The company's cash flow from operating activities was ¥29,203,067.45, a decrease of 13.17% from ¥33,634,255.83 in the same period last year[4] - Cash inflow from operating activities totaled CNY 84,423,272.12, a decrease of 33.4% from CNY 126,519,782.52 in the previous period[22] - Net cash flow from operating activities was CNY 29,203,067.45, down 13.0% from CNY 33,634,255.83 in the previous period[22] - The company's cash and cash equivalents decreased to ¥56,031,185.20 from ¥66,528,821.44 at the beginning of the year, a decline of approximately 15.0%[16] - Cash and cash equivalents at the end of the period were CNY 56,031,185.20, down from CNY 120,388,006.24 at the end of the previous period, a decrease of 53.4%[23] - The net cash flow from investing activities was -¥38,641,572.58, a decrease of 297.52% compared to ¥19,563,148.39 in the previous year[11] - Cash inflow from investment activities was CNY 192,012,667.99, an increase of 27.5% compared to CNY 150,610,080.08 in the previous period[23] - The company reported a total cash outflow from financing activities of CNY 881,282.29, compared to CNY 397,914.00 in the previous period, indicating an increase of 121.1%[23] Assets and Liabilities - Total assets at the end of the reporting period were ¥746,182,705.65, a slight decrease of 0.20% from ¥747,689,257.68 at the end of the previous year[4] - Total liabilities decreased to ¥39,456,244.12 from ¥57,431,623.26, reflecting a reduction of 31.2%[18] - The company's total assets amounted to ¥746,182,705.65, slightly down from ¥747,689,257.68 at the end of the previous period[18] - Total current assets increased slightly to ¥532,837,886.84 from ¥528,698,264.03, reflecting a growth of about 0.4%[16] - The company's trading financial assets rose to ¥346,198,392.23 from ¥306,106,366.51, an increase of approximately 13.1%[16] - Accounts receivable decreased to ¥44,816,148.07 from ¥47,226,794.95, a decline of about 8.8%[16] - Inventory decreased to ¥35,204,754.57 from ¥40,176,556.36, representing a decrease of approximately 12.4%[16] Shareholder Information - Total number of common shareholders at the end of the reporting period is 10,571[13] - The largest shareholder, Xiang Hongwei, holds 52.81% of shares, totaling 74,059,325 shares[13] - The top 10 shareholders include various individuals and asset management entities, with the second-largest holding at 3.21%[13] - There are no preferred shareholders reported in the current financial summary[15] Government Support and Other Income - The company received government subsidies amounting to ¥1,912,472.86 during the reporting period, which is a significant increase of 301.73% compared to ¥476,061.75 in the previous year[10] - The fair value change income was ¥852,540.17, an increase of 284.73% from ¥221,596.35 in the same period last year[10] Research and Development - Research and development expenses for Q1 2023 were ¥5,753,424.68, a slight decrease from ¥5,950,586.48 in the previous year[19] - The company has ongoing investments in new technologies and product development, although specific details were not disclosed in the report[19] - The company has not disclosed any new product developments or market expansion strategies in the current report[15] Future Outlook - Future outlook remains cautious due to market conditions, with a focus on cost control and efficiency improvements[19] - The first quarter report was not audited, indicating that the figures may be subject to change upon final audit[24]